Lotus Eye Hospital & Institute (BOM:532998) ROC %: -2.14% (As of Mar. 2026)


BOM:532998 Lotus Eye Hospital & Institute Ltd BOM:532998
66 GF Score
Price ₹126.50
GF Value ₹91.88
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Lotus Eye Hospital & Institute ROC %?

Lotus Eye Hospital & Institute BOM:532998 +5.90% 66 ROC % is -2.14% as of Mar. 2026. GuruFocus rates BOM:532998 with a GF Score™ of 66/100 and a GF Value™ of ₹91.88 (Significantly Overvalued). The stock has 3 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Lotus Eye Hospital & Institute's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was -2.14%.

As of today (2026-07-03), Lotus Eye Hospital & Institute's WACC % is 13.15%. Lotus Eye Hospital & Institute's ROC % is 0.00% (calculated using TTM income statement data). Lotus Eye Hospital & Institute earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Lotus Eye Hospital & Institute  (BOM:532998) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Lotus Eye Hospital & Institute's WACC % is 13.15%. Lotus Eye Hospital & Institute's ROC % is 0.00% (calculated using TTM income statement data). Lotus Eye Hospital & Institute earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Lotus Eye Hospital & Institute ROC % Related Terms


Lotus Eye Hospital & Institute ROC % Historical Data

* Premium members only.

The historical data trend for Lotus Eye Hospital & Institute's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Eye Hospital & Institute ROC % Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.13 6.69 3.96 0.39 0.00

Lotus Eye Hospital & Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 3.20 -0.45 -1.38 -2.14
BOM:532998
66GF Score
Lotus Eye Hospital & Institute Ltd BOM:532998
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Eye Hospital & Institute ROC % Calculation

Lotus Eye Hospital & Institute's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=-3.665 * ( 1 - 100% )/( (612.929 + 773.187)/ 2 )
=-0/693.058
=0.00 %

where

Lotus Eye Hospital & Institute's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-24.972 * ( 1 - 33.62% )/( (0 + 773.187)/ 1 )
=-16.5764136/773.187
=-2.14 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -2.14% mean?
Lotus Eye Hospital & Institute (BOM:532998) has a ROC % of -2.14% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Lotus Eye Hospital & Institute and its competitors.
Is Lotus Eye Hospital & Institute's ROC % too high?
Lotus Eye Hospital & Institute's current ROC % is -2.14%. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's ROC % compare to HCA and THC?
Lotus Eye Hospital & Institute's ROC % of -2.14% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROC % is 3.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Healthcare Providers & Services company?
The median ROC % among Healthcare Providers & Services companies is 3.08, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median ROC % is 3.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current ROC % is -2.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹91.88, compared to a current price of ₹126.50 — trading 37.7% above its estimated fair value. The current ROC % is -2.14%. Lotus Eye Hospital & Institute's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current ROC % is -2.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued. The current stock price of ₹126.50 is trading 37.7% above its estimated GF Value™ of ₹91.88. GuruFocus considers Lotus Eye Hospital & Institute to be Significantly Overvalued.

Key valuation signals for BOM:532998:

  • ROC %: -2.14%
  • GF Value™: ₹91.88 vs. price of ₹126.50 (37.7% above fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lotus Eye Hospital & Institute Business Description

Other Exchanges LOTUSEYE:India
Address SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
66GF Score

Get the complete analysis for BOM:532998

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹126.50
Price
₹91.88
GF Value